Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Goerner's contract = proof of 1:5 R/S? gcduck...
"ease, I don't think gcduck is suggesting that a split will be implemented until after the SP is one dollar, i.e. M&A is accomplished and revenue is more or less stabilized."
Exactly.
First it seems to be RG's job to bring back the shareprice to ONE Dollar, which means 400mio shares at $1 = $400 mio market cap.
The company seems not to expect the USPTO decisions alone to be that strong, that the shareprice will rise to $1 - it seems, this has to be "job" of RG...;-)
Thus, M&A and a more reliable revenue are seen as the main factors to bring PTSC to $1.
And AFTER PTSC reached the $1 limit, the next step has to be a R/S to reach $5.
Maybe I can explain it in german....lol...?
@fatwollit: I thought it was you, who wrote about the 18th and 19th letter of the alphabet yesterday?
Share
New Message
Please login to post a reply